- Vaccines are the best way to prevent pneumococcal disease
- Antibiotics such as amoxicillin are the first-line treatment for pneumococcal infections
- Oxygen Therapy can help treat pneumonia but is often a scarce resource for children in low-resource settings
- Exclusive Breastfeeding
- Good Nutrition
- Hand Washing
- Abating indoor air pollution
- Spreads through contact with people who carry the bacteria in their nose and throat.
- Transmission occurs from respiratory droplets from the nose or mouth of an infected person.
- People, especially children, can be carriers without being sick and spread the bacterium to others.
- Exposure to tobacco smoke
- Poor nutrition
- HIV infection
- Poor shelter
- Indoor or outdoor pollution
- Lack of appropriate breastfeeding for the first six months of life
- Inadequate zinc intake.
Two of the biggest drivers for why new PCVS are needed are increasing supply and lowering costs.
- The process of making PCVS is one of the most complex and expensive as far as vaccines go.
- Existing PCVS save lives but are too expensive for many countries to afford without considerable donor support and many unable to access financial support simply can’t afford them at all.
We urgently need a vaccine that protects on par with current ones but is significantly less expensive so that countries can afford and access them over the long term. Pneumosil is designed to meet this need.
SIIPL can make Pneumosil relatively cost efficiently at high volume-which can make vaccine easier to supply and more accessibie over the long term for the countries that.need it most.
The process of making PCVS is one of the most complex and expensive as far as vaccines go.
Pneumosil is made similarly, but parts of the process have been made more efficient-lowering costs while preserving quality.
Pneumosil is designed to provide the same degree of protection as current vaccines at roughly 30% of the GAVI supported price for LICS and at substantially lower pricing than current vaccines for other LMICS-savings that could free up funds for other health priorities.